Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
Social disruption alters pain and cognition in an animal model of multiple sclerosis.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
Risk factors for idiopathic optic neuritis recurrence.
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Magnetic Resonance Spectroscopy: A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
What is new in MS spasticity research? Poster session highlights.
Allogeneic Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica.
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Pages
« first
‹ previous
…
348
349
350
351
352
353
354
355
356
…
next ›
last »